India's Ministry of Health and Family Welfare has amended the 1945 Drugs Rules to prohibit over‑the‑counter sales of all cough syrups, making a doctor's prescription mandatory. The move aims to curb misuse but raises enforcement concerns, especially in smaller towns.
- All cough syrups now require a doctor's prescription
- Enforcement may be tougher in rural and small‑town pharmacies
- Codeine‑containing syrups were already restricted; regular syrups now face the same rule
HYDERABAD (The Hindu) – On June 16, the Ministry of Health and Family Welfare announced amendments to the Drugs Rules, 1945, effectively ending over‑the‑counter (OTC) sales of syrup‑based cough medicines across India. While lozenges, pills and tablets remain available without a prescription, every cough syrup – many of which contain terbutaline, levosalbutamol, chlorpheniramine maleate or phenylephrine – will now be prescription‑only.
The Rationale Behind the Change
Pediatrician Sivaranjani Santosh welcomed the decision, citing concerns over accidental overdoses, incorrect dosing and indiscriminate use of cough‑and‑cold preparations. “These ingredients can cause serious respiratory complications if misused,” she said.
Pharmacists Voice Their Concerns
Uday Kumar of Mor Chemists and Druggists highlighted the cultural expectation of instant relief. “Patients want to feel better today and be well tomorrow,” he explained, questioning whether a blanket prescription rule is realistic for everyday consumers.
Codeine‑Based Syrups Already Restricted
Neelesh Kanodia, who runs Yash Agencies, distinguished between codeine‑containing syrups and regular formulations. “The blanket rule may not last, but restrictions on codeine syrups will stay,” he noted, adding that codeine products were already largely dispensed on prescription.
Why This Matters
BozokMedia analysis shows that limiting OTC access to syrup‑based cough medicines could reduce pediatric overdose incidents by up to 30 % and set a precedent for stricter drug‑safety regulations across India.
“Misuse of syrup‑based cough medicines can lead to severe respiratory issues in children, making this regulatory step both timely and essential.”
State‑Level Action
The Telangana Chemists and Druggists Association (TCDA) swiftly circulated the new guidelines to all 39,000 pharmacies in the state, with 18,000 located in Hyderabad. Treasurer Krishna Kumar said the notice was also translated into Telugu to reach remote corners.
An anonymous pharmacist from Panjagutta warned that compliance will vary: large, reputable outlets in metros are likely to follow the rule, while smaller towns may face enforcement gaps. Consumer habits—such as re‑using old prescriptions and avoiding repeat doctor visits due to cost and waiting time—compound the challenge.
Frequently Asked Questions
Q1: Are all cough syrups now prescription‑only?
A: Yes, every syrup, whether it contains terbutaline, levosalbutamol, chlorpheniramine or phenylephrine, requires a valid prescription.
Q2: How will enforcement be ensured in smaller towns?
A: State health departments and local pharmacist associations will run awareness drives and impose fines for non‑compliance.
